DUBLIN--(BUSINESS WIRE)--The "Thailand Legal Cannabis Market Size, Share & Trends Analysis Report by Derivative (Marijuana, Hemp), by Sources (CBD, THC), by End-use (Medical Use, Recreational Use, Industrial Use), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The Thailand legal cannabis market size is expected to reach USD 9.6 billion by 2030 and is anticipated to expand at a CAGR of 58.4% from 2022 to 2030

The growth is attributed to the rising usage of cannabis for recreational and medical purposes. Cannabis legalization has opened new revenue-generating opportunities for various industries in the country. The adoption of CBD oil and tinctures for treating various ailments like nausea, anxiety, and cancer along with the rising prevalence of cancer are some of the significant factors boosting the industry's growth.

The growing burden of chronic pain has also augmented the rise in the usage of CBD for treatments related to pain management and thus, positively impacting the market growth. Various studies have shown positive outcomes of marijuana and its derivatives to treat symptoms of several chronic conditions.

For instance, it has been effectively used to treat patients dealing with chronic pain, nausea induced by chemotherapy, and neurological diseases such as Alzheimer's and Parkinson's. Hence, FDA and other government organizations are permitting marijuana derivatives for the prescription of several diseases. This is one of the key factors for the quick turnaround.

In 2018, Thailand legalized the adoption of cannabis for medical purposes. Furthermore, in June 2022, the government decriminalized the distribution, cultivation, consumption, and marketing of all the parts of the cannabis plant. The Thai Food and Drug Administration has also removed the cannabis plant from the Category 5 narcotics list. Although, smoking cannabis in public areas is still illegal.

Furthermore, the rising disposable income of the country, increasing healthcare expenditure, a surge in social acceptance of CBD for its therapeutic applications, and an increasing number of product launches, along with improvements in intellectual property rights of Thailand are some of the key reasons that are expected to fuel the business growth.

Moreover, with this legalization, more domestic players are planning to explore the CBD market and key players are also planning strategic initiatives to expand their product portfolio and regional domination through mergers & acquisitions, collaborations, partnerships, funding & investments. For instance, in December 2020, Tilray Brand s Inc. merged with Aphria and will operate under the name Tilray. Such factors also fuel the industry's growth.

The growing trend of cannabis-infused food and beverages and the rising adoption of CBD oil by cosmetics and wellness industries also boost the industry's growth within the country.

Thailand Legal Cannabis Market Report Highlights

• The hemp segment dominated the Thailand legal cannabis industry in 2021 and accounted for the largest revenue share of 88.4%. Growing usage of hemp for industrial purposes is one of the key factors fueling the segment's growth
• The CBD segment held the largest revenue share of about 68.4% in 2021. The growth of the segment is attributed to the rising acceptance of CBD by consumers. However, the THC segment is expected to grow at the fastest CAGR of 61.4%
• In 2021, the industrial segment held the largest revenue share at 81.9%. Growing adoption of CBD by various industries such as wellness and cosmetics, food and beverages, and others are projected to boost the segment's growth

Company Profiles

• Pharmahemp
• Thc Thailand Group Ltd.
• Medipharm Labs, Inc.
• Cresco Labs
• Elixinol Thailand Limited
• Tilray
• Extractas
• Bol Pharma
• Canopy Growth Corporation

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

2.4 Thailand Legal Cannabis Market Snapshot

Chapter 3 Thailand Legal Cannabis Market Variables, Trends & Scope

3.1 Market Segmentation

3.2 Penetration and Growth Prospect Mapping

3.3 Market Dynamics

3.3.1 Market Driver Analysis

3.3.2 Market Restraint Analysis

3.4 Thailand Legal Cannabis Industry: History Of Medical Use Of Cannabis

3.5 Thailand Legal Cannabis Industry: History Of Industrial Use Of Cannabis

3.6 Thailand Legal Cannabis Industry: Number Of Clinical Trials

3.7 Thailand Legal Cannabis Industry: Legalization Timeline

3.8 Thailand Legal Cannabis Industry: Consumption Pattern Analysis

3.9 Thailand Legal Cannabis Industry: Country Case Studies

3.9.1 Thailand

3.9.1.1 Legalization Of Cannabis

3.9.1.2 Licensing And Import/Export Scenario As Per Legalization Regulations

3.9.1.3 Reason For Legalization

3.9.1.4 Scenario After Legalization

3.9.1.5 Competitive Landscape Post Legalization:

Chapter 4 Thailand Legal Cannabis Market: Source Estimates & Trend Analysis

4.1 Segment Dashboard

4.2 Thailand Legal Cannabis Market: Source Movement Analysis, (USD Million) 2021 & 2030

4.2.1 Marijuana

4.2.1.1 Marijuana Market Estimates And Forecasts, 2018 - 2030 (USD Million)

4.2.1.2 Flowers

4.2.1.3 Oil And Tinctures

4.2.2 Hemp

4.2.2.1 Hemp Market Estimates And Forecasts, 2018 - 2030 (USD Million)

4.2.2.2 Hemp CBD

4.2.2.3 Supplements

4.2.2.4 Industrial Hemp

Chapter 5 Thailand Legal Cannabis Market: Derivative Estimates & Trend Analysis

5.1 Segment Dashboard

5.2 Thailand Legal Cannabis Market: Derivative Movement Analysis, USD Million, 2021 & 2030

5.2.1 CBD

5.2.1.1 CBD Market Estimates And Forecasts, 2018 - 2030 (USD Million)

5.2.2 THC

5.2.3 Others

Chapter 6 Thailand Legal Cannabis Market: End-Use Estimates & Trend Analysis

6.1 Segment Dashboard

6.2 Thailand Legal Cannabis Market: End-Use Movement Analysis, USD Million, 2021 & 2030

6.2.1 Medical Use

6.2.1.1 Medical Use Market Estimates And Forecasts, 2018 - 2030 (USD Million)

6.2.1.2 Cancer

6.2.1.3 Chronic Pain

6.2.1.4 Depression And Anxiety

6.2.1.5 Arthritis

6.2.1.6 Diabetes

6.2.1.8 Migraines

6.2.1.9 Epilepsy

6.2.1.10 Multiple Sclerosis

6.2.1.11 AIDS

6.2.1.12 Amyotrophic Lateral Sclerosis

6.2.1.13 Alzheimer's Disease

6.2.1.14 Post-Traumatic Stress Disorder (Ptsd)

6.2.1.15 Parkinson's Disease

6.2.1.16 Tourette Syndrome

6.2.1.17 Others

6.2.2 Recreational Use

6.2.3 Industrial Use

Chapter 7 Thailand Legal Cannabis Market: Competitive Analysis

7.1 Company Market Position Analysis

7.2 Strategic Framework

Chapter 8 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/spulx

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900